Article ID Journal Published Year Pages File Type
5702168 Practical Radiation Oncology 2017 20 Pages PDF
Abstract
DIBH reduced ipsilateral lung V20Gy by ≥5% in the majority of patients. For some patients, the volume of liver receiving a potentially toxic dose decreased with DIBH. DIBH should be available as a treatment strategy to reduce ipsilateral lung V20Gy prior to compromising internal mammary chain nodal coverage for patients with right-sided breast cancer during locoregional radiation therapy if the V20Gy on FB exceeds 30%.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , ,